Literature DB >> 12804106

An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid.

Yasuhiro Ito1, Takashi Uruno, Keiichi Nakano, Yuuki Takamura, Akihiro Miya, Kaoru Kobayashi, Tamotsu Yokozawa, Fumio Matsuzuka, Seiji Kuma, Kanji Kuma, Akira Miyauchi.   

Abstract

The recent prevalence of ultrasound-guided fine-needle aspiration biopsy has resulted in a marked increase in the number of patients with papillary microcarcinoma (maximum diameter, </= 10 mm) of the thyroid detected by this sophisticated tool. On the other hand, it is debatable whether patients with papillary microcarcinoma should always undergo surgery after diagnosis, because a high incidence of occult papillary carcinoma has been observed in autopsy studies. Thus, we proposed observation without surgical therapy as a treatment option in 732 patients diagnosed with papillary microcarcinoma by the above technique from 1993 to 2001. One hundred sixty-two patients chose observation and were classified as the observation group. During the follow-up period for patients in the observation group, more than 70% of tumors either did not change or decreased in size compared to their initial size at diagnosis. They enlarged by more than 10 mm in 10.2%, and lymph node metastasis in the lateral compartments appeared in only 1.2% of patients during follow-up. On the other hand, 570 patients chose surgical treatment at diagnosis and 56 patients in the observation group who underwent surgery after a period of follow-up were classified as the surgical treatment group. Of these 626 patients, lymph node dissection was performed in 594 patients, and metastasis was confirmed histologically in 50.5%. Multiple tumor formation was seen in 42.8% of patients. In this group, the rate of recurrence was 2.7% at 5 years and 5.0% at 8 years after surgery. Our preliminary data suggest that papillary microcarcinomas do not frequently become clinically apparent, and that patients can choose observation while their tumors are not progressing, although they are pathologically multifocal and involve lymph nodes in high incidence.

Entities:  

Mesh:

Year:  2003        PMID: 12804106     DOI: 10.1089/105072503321669875

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  213 in total

1.  Screening without evidence of efficacy: thyroid ultrasonography is another example.

Authors:  Yair Liel
Journal:  BMJ       Date:  2004-02-28

2.  In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival.

Authors:  Mauricio A Moreno; Beth S Edeiken-Monroe; Eric R Siegel; Steven I Sherman; Gary L Clayman
Journal:  Thyroid       Date:  2012-01-26       Impact factor: 6.568

3.  Is surgery necessary for papillary thyroid microcarcinomas?

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  Nat Rev Endocrinol       Date:  2011-12-06       Impact factor: 43.330

4.  Total versus hemithyroidectomy for microscopic papillary thyroid cancer.

Authors:  M Gershinsky; O Barnett-Griness; N Stein; D Hirsch; G Tzvetov; O Bardicef; J Pauker; S Grozinsky-Glasberg; S Ish-Shalom; I Slutski; I Shimon; C Benbassat
Journal:  J Endocrinol Invest       Date:  2011-09-27       Impact factor: 4.256

5.  Negative Fine-Needle Aspiration in Patients with Goiter: Should We Doubt It?

Authors:  Michal Mekel; Hayim Gilshtein; Abbas Al-Kurd; Bishara Bishara; Michael M Krausz; Herbert R Freund; Yoram Kluger; Ahmed Eid; Haggi Mazeh
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

6.  The role of preoperative neck ultrasounds to assess lymph nodes in patients with suspicious or indeterminate thyroid nodules.

Authors:  Rashmi Roy; Guennadi Kouniavsky; Raghunandan Venkat; Erin A Felger; Zita Shiue; Eric Schneider; Martha A Zeiger
Journal:  J Surg Oncol       Date:  2011-10-17       Impact factor: 3.454

7.  Association of Patient Age With Progression of Low-risk Papillary Thyroid Carcinoma Under Active Surveillance: A Systematic Review and Meta-analysis.

Authors:  Alexandra Koshkina; Rouhi Fazelzad; Iwao Sugitani; Akira Miyauchi; Lehana Thabane; David P Goldstein; Sangeet Ghai; Anna M Sawka
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-06-01       Impact factor: 6.223

8.  The prevalence and prognostic value of BRAF mutation in thyroid cancer.

Authors:  Electron Kebebew; Julie Weng; Juergen Bauer; Gustavo Ranvier; Orlo H Clark; Quan-Yang Duh; Daniel Shibru; Boris Bastian; Ann Griffin
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

9.  Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid.

Authors:  Yasuhiro Ito; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

10.  Thyroid cancer detected by mass screening over a period of 16 years at a health care center in Japan.

Authors:  Fumie Suehiro
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.